Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024
Revenue:
Product revenue, net	$ 10,612	$ 45,274
Other revenue	0	12
Total revenues	10,612	45,286
Cost of product revenue	11,781	66,591
Gross margin	(1,169)	(21,305)
Operating expenses:
Selling, general and administrative	39,765	136,479
Research and development	23,174	73,408
Restructuring expenses	2,811	2,811
Total operating expenses	65,750	212,698
Gain from sale of priority review voucher, net	0	0
Loss from operations	(66,919)	(234,003)
Interest income	1,640	7,056
Interest expense	(5,778)	(16,875)
Other income, net	10,191	31,782
Loss before income taxes	(60,866)	(212,040)
Income tax (expense) benefit	58	37
Net loss	$ (60,808)	$ (212,003)
Net loss per share - basic (in dollars per share)	$ (0.31)	$ (1.10)
Net loss per share - diluted (in dollars per share)	$ (0.31)	$ (1.10)
Weighted-average number of common shares used in computing net loss per share - basic (in shares)	193,893	193,588
Weighted-average number of common shares used in computing net loss per share - diluted (in shares)	193,893	193,588
Other comprehensive income (loss):
Total other comprehensive income (loss)	$ 611	$ 285
Comprehensive loss	$ (60,197)	$ (211,718)